Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 20

1.

Parkinson's-adapted cognitive stimulation therapy: a pilot randomized controlled clinical trial.

Leroi I, Vatter S, Carter LA, Smith SJ, Orgeta V, Poliakoff E, Silverdale MA, Raw J, Ahearn DJ, Taylor C, Rodda J, Abdel-Ghany T, McCormick SA.

Ther Adv Neurol Disord. 2019 Jul 4;12:1756286419852217. doi: 10.1177/1756286419852217. eCollection 2019.

2.

Parkinson's-adapted cognitive stimulation therapy: feasibility and acceptability in Lewy body spectrum disorders.

McCormick SA, Vatter S, Carter LA, Smith SJ, Orgeta V, Poliakoff E, Silverdale MA, Raw J, Ahearn DJ, Taylor C, Rodda J, Abdel-Ghany T, Kwapong B, Leroi I.

J Neurol. 2019 Jul;266(7):1756-1770. doi: 10.1007/s00415-019-09329-6. Epub 2019 Jun 4.

3.

Care Burden and Mental Ill Health in Spouses of People With Parkinson Disease Dementia and Lewy Body Dementia.

Vatter S, Stanmore E, Clare L, McDonald KR, McCormick SA, Leroi I.

J Geriatr Psychiatry Neurol. 2019 May 30:891988719853043. doi: 10.1177/0891988719853043. [Epub ahead of print]

PMID:
31146617
4.

Multidimensional Care Burden in Parkinson-Related Dementia.

Vatter S, McDonald KR, Stanmore E, Clare L, Leroi I.

J Geriatr Psychiatry Neurol. 2018 Nov;31(6):319-328. doi: 10.1177/0891988718802104. Epub 2018 Sep 24.

PMID:
30244631
5.

Dementia in 'super-aged' Japan: challenges and solutions.

Leroi I, Kitagawa K, Vatter S, Sugihara T.

Neurodegener Dis Manag. 2018 Aug;8(4):257-266. doi: 10.2217/nmt-2018-0007. Epub 2018 Jul 24. Review.

PMID:
30040019
6.

A qualitative study of female caregiving spouses' experiences of intimate relationships as cognition declines in Parkinson's disease.

Vatter S, McDonald KR, Stanmore E, Clare L, McCormick SA, Leroi I.

Age Ageing. 2018 Jul 1;47(4):604-610. doi: 10.1093/ageing/afy049.

7.

In-vitro blockade of the CD4 receptor co-signal in antigen-specific T-cell stimulation cultures induces the outgrowth of potent CD4 independent T-cell effectors.

Vatter S, Schmid M, Gebhard C, Mirbeth C, Klobuch S, Rehli M, Herr W, Thomas S.

J Immunol Methods. 2018 Mar;454:80-85. doi: 10.1016/j.jim.2017.11.006. Epub 2017 Nov 14.

PMID:
29154771
8.

Psychosocial therapy for Parkinson's-related dementia: intervention development.

McCormick SA, McDonald KR, Vatter S, Orgeta V, Poliakoff E, Smith SJ, Leroi I.

Clin Interv Aging. 2017 Oct 20;12:1779-1789. doi: 10.2147/CIA.S143006. eCollection 2017.

9.

Psychosocial therapy for Parkinson's-related dementia: study protocol for the INVEST randomised controlled trial.

McCormick SA, McDonald KR, Vatter S, Orgeta V, Poliakoff E, Smith S, Silverdale MA, Fu B, Leroi I.

BMJ Open. 2017 Jun 19;7(6):e016801. doi: 10.1136/bmjopen-2017-016801.

10.

Identification of a Water-Soluble Indirubin Derivative as Potent Inhibitor of Insulin-like Growth Factor 1 Receptor through Structural Modification of the Parent Natural Molecule.

Cheng X, Merz KH, Vatter S, Zeller J, Muehlbeyer S, Thommet A, Christ J, Wölfl S, Eisenbrand G.

J Med Chem. 2017 Jun 22;60(12):4949-4962. doi: 10.1021/acs.jmedchem.7b00324. Epub 2017 Jun 6.

PMID:
28557430
11.

HLA-DPB1 mismatch alleles represent powerful leukemia rejection antigens in CD4 T-cell immunotherapy after allogeneic stem-cell transplantation.

Herr W, Eichinger Y, Beshay J, Bloetz A, Vatter S, Mirbeth C, Distler E, Hartwig UF, Thomas S.

Leukemia. 2017 Feb;31(2):434-445. doi: 10.1038/leu.2016.210. Epub 2016 Aug 1.

PMID:
27479183
12.

7,7'-Diazaindirubin--a small molecule inhibitor of casein kinase 2 in vitro and in cells.

Cheng X, Merz KH, Vatter S, Christ J, Wölfl S, Eisenbrand G.

Bioorg Med Chem. 2014 Jan 1;22(1):247-55. doi: 10.1016/j.bmc.2013.11.031. Epub 2013 Nov 25.

PMID:
24326279
13.

Synthesis and cytotoxicity of novel indirubin-5-carboxamides.

Cheng X, Rasqué P, Vatter S, Merz KH, Eisenbrand G.

Bioorg Med Chem. 2010 Jun 15;18(12):4509-15. doi: 10.1016/j.bmc.2010.04.066. Epub 2010 Apr 28.

PMID:
20488718
14.

Limited stability in cell culture medium and hydrogen peroxide formation affect the growth inhibitory properties of delphinidin and its degradation product gallic acid.

Kern M, Fridrich D, Reichert J, Skrbek S, Nussher A, Hofem S, Vatter S, Pahlke G, Rüfer C, Marko D.

Mol Nutr Food Res. 2007 Sep;51(9):1163-72.

PMID:
17729219
15.

Biological activities of malvidin, a red wine anthocyanidin.

Fritz J, Kern M, Pahlke G, Vatter S, Marko D.

Mol Nutr Food Res. 2006 Apr;50(4-5):390-5.

PMID:
16598815
16.

Searching for cellular targets of novel pteridines downstream of cAMP PDE inhibition.

Vatter S, Merz KH, Eisenbrand G.

Int J Clin Pharmacol Ther. 2005 Dec;43(12):607-8. No abstract available.

PMID:
16372537
17.

Molecular targets of indirubins.

Jakobs S, Merz KH, Vatter S, Eisenbrand G.

Int J Clin Pharmacol Ther. 2005 Dec;43(12):592-4. No abstract available.

PMID:
16372530
18.

Indirubin derivatives inhibit Stat3 signaling and induce apoptosis in human cancer cells.

Nam S, Buettner R, Turkson J, Kim D, Cheng JQ, Muehlbeyer S, Hippe F, Vatter S, Merz KH, Eisenbrand G, Jove R.

Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):5998-6003. Epub 2005 Apr 18.

19.
20.

Biological activity and physicochemical parameters of marine halogenated natural products 2,3,3',4,4',5,5'-heptachloro-1'-methyl-1,2'-bipyrrole and 2,4,6-tribromoanisole.

Vetter W, Hahn ME, Tomy G, Ruppe S, Vatter S, Chahbane N, Lenoir D, Schramm KW, Scherer G.

Arch Environ Contam Toxicol. 2005 Jan;48(1):1-9.

PMID:
15657799

Supplemental Content

Loading ...
Support Center